Anda belum login :: 24 Nov 2024 01:02 WIB
Detail
ArtikelOocyte maturation employing a GnRH agonist in combination with low-dose hCG luteal rescue minimizes the severity of ovarian hyperstimulation syndrome while maintaining excellent pregnancy rates  
Oleh: Radesic, B. ; Tremellen, K.P.
Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: Human Reproduction vol. 26 no. 12 (Dec. 2011), page 3437-3442.
Topik: Luteal phase; GnRH agonist/antagonist; hCG; oocyte maturation; OHSS
Ketersediaan
  • Perpustakaan FK
    • Nomor Panggil: H07.K.2011.02
    • Non-tandon: 1 (dapat dipinjam: 0)
    • Tandon: tidak ada
    Lihat Detail Induk
Isi artikelBACKGROUND The traditional hCG ‘trigger’ for initiating final oocyte maturation exacerbates ovarian hyperstimulation syndrome (OHSS) in patients with an excessive follicular response because of its sustained stimulatory effect on the corpora lutea. However, a GnRH agonist trigger can produce a short duration endogenous LH surge which is adequate to initiate oocyte maturation, but allows the corpora lutea to regress, reducing the severity of OHSS. This approach produces an excellent embryology outcome, but generally results in low pregnancy rates even with the early initiation of estrogen and progesterone luteal support. The purpose of this study was to determine if a low dose of hCG (1500 IU) support on the day of oocyte retrieval can maintain good pregnancy rates, while not abolishing the protective effect of an agonist trigger on the development of severe OHSS. METHODS This retrospective study included 71 women who were at high risk of severe OHSS (=14 follicles =12 mm) and who received an agonist trigger for final oocyte maturation. RESULTS The transfer of a solitary embryo produced a biochemical pregnancy rate of 60.6% and a clinical ongoing pregnancy rate of 52.1%. Only one patient was hospitalized with severe OHSS (1.4%), despite the average patient producing nearly 17 oocytes per cycle. CONCLUSIONS Oocyte maturation employing a GnRH agonist (protocol) in combination with low-dose hCG luteal support produces excellent clinical pregnancy rates, while not compromising the ability of GnRH agonist to prevent severe OHSS.
Opini AndaKlik untuk menuliskan opini Anda tentang koleksi ini!

Kembali
design
 
Process time: 0.015625 second(s)